May 1, 2012 By:Peter O'Donnell
Clinical trials should meet ethical and GCP standards no matter where in the world they are conducted.
 |
April 1, 2012 By:Peter O'Donnell
The new Executive Director of the EMA has managed to stay calm under financial and political pressure.
 |
March 1, 2012 By:Peter O'Donnell
European Forum for Good Clinical Practice meeting on informed consent draws a huge crowd.
 |
February 1, 2012 By:Peter O'Donnell
Europe's struggling economies may have unexpected effects on the pharmaceutical sector.
 |
January 1, 2012 By:Peter O'Donnell
Patricia Brunko addresses the decline in European clinical trials, but still gives the industry hope.
 |
December 1, 2011 By:Peter O'Donnell
The management board has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director, and the monitoring of the Agency's performance.
 |
November 1, 2011 By:Peter O'Donnell
The Innovative Medicines Initative has launched several projects to improve quality of life.
 |
October 1, 2011 By:Peter O'Donnell
EU's new rules will be influenced by more than just those primarily responsible for pharmaceuticals.
 |
September 1, 2011 By:Peter O'Donnell
EU's new rules will be influenced by more than just those primarily responsible for pharmaceuticals.
 |
|